These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 26506219

  • 1. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W, Dong M, Deng J, Yan D, Liu Y, Xu T, Liu J.
    Am J Physiol Heart Circ Physiol; 2014 Sep 01; 307(5):H792-802. PubMed ID: 25015961
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X, Li J, Wang X, Chen N, Cai B, Wang G, Shan H, Dong D, Liu Y, Li X, Yang F, Li X, Zhang P, Li X, Yang B, Lu Y.
    Int J Biol Sci; 2011 Apr 07; 7(3):383-9. PubMed ID: 21494433
    [Abstract] [Full Text] [Related]

  • 5. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y, Yuan J, Jiang G, Zhu J, Zou Y, Lv Q.
    Mol Med Rep; 2017 Oct 07; 16(4):4545-4552. PubMed ID: 28849081
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X, Xia J, Qian D, Wang Y, Lin Y, Huang X, Tan J.
    Cardiology; 2014 Oct 07; 129(3):153-62. PubMed ID: 25277512
    [Abstract] [Full Text] [Related]

  • 8. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G, Pan SQ, Shen C, Pan SF, Zhang XM, He QY.
    Acta Pharmacol Sin; 2014 Apr 07; 35(4):463-75. PubMed ID: 24608673
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y, Li Y, Nakagawa Y, Usami S, Fujiwara M, Yamada Y, Minami T, Ueshima K, Nakao K.
    Circ Res; 2010 Jun 25; 106(12):1849-60. PubMed ID: 20448219
    [Abstract] [Full Text] [Related]

  • 11. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W, Deng J, Ding W, Wang G, Shen Y, Zheng J, Zhang X, Luo Y, Lv C, Wang Y, Chen L, Yan D, Boudreau RL, Song LS, Liu J.
    Circ Heart Fail; 2017 Jun 25; 10(6):. PubMed ID: 28611128
    [Abstract] [Full Text] [Related]

  • 12. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C, Wang Y, Ge Z, Lin J, Liu J, Yuan X, Lin Z.
    Curr Mol Med; 2018 Jun 25; 18(10):661-671. PubMed ID: 30714521
    [Abstract] [Full Text] [Related]

  • 13. Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.
    Gitau SC, Li X, Zhao D, Guo Z, Liang H, Qian M, Lv L, Li T, Xu B, Wang Z, Zhang Y, Xu C, Lu Y, Du Z, Shan H, Yang B.
    Front Med; 2015 Dec 25; 9(4):444-56. PubMed ID: 26626190
    [Abstract] [Full Text] [Related]

  • 14. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
    Liu CJ, Cheng YC, Lee KW, Hsu HH, Chu CH, Tsai FJ, Tsai CH, Chu CY, Liu JY, Kuo WW, Huang CY.
    Mol Cell Biochem; 2008 Jun 25; 313(1-2):167-78. PubMed ID: 18398669
    [Abstract] [Full Text] [Related]

  • 15. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, Patten RD.
    Circ Res; 2009 Jan 30; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [Abstract] [Full Text] [Related]

  • 16. VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca2+ -mediated PKG I pathway.
    Shen Z, Zhang Z, Wang X, Yang K.
    J Cell Biochem; 2018 Feb 30; 119(2):1511-1520. PubMed ID: 28771828
    [Abstract] [Full Text] [Related]

  • 17. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D, Kim JM, Cha H, Oh JG, Park J, Yun SH, Ju ES, Jeon ES, Hajjar RJ, Park WJ.
    Circ Res; 2008 Mar 28; 102(6):711-9. PubMed ID: 18258855
    [Abstract] [Full Text] [Related]

  • 18. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
    Li Y, Zhou WW, Sun JH, Yang HX, Xu GR, Zhang Y, Song QH, Zhang C, Liu WZ, Liu XC, Li AY.
    Biomed Pharmacother; 2021 Nov 28; 143():112178. PubMed ID: 34649308
    [Abstract] [Full Text] [Related]

  • 19. [Effects of hydrogen sulfide (H2S) on cardiac hypertrophy and miRNA-133a-mediated Ca2+/calcineurin/NFATc4 signal pathway in rats].
    Wu Y, Guo YY, Zhang YY, Zhang Y.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan 08; 34(1):29-34. PubMed ID: 29926655
    [Abstract] [Full Text] [Related]

  • 20. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
    Wang NN, Wang J, Tan HL, Wang YG, Gao Y, Ma ZC.
    Zhongguo Zhong Yao Za Zhi; 2019 Apr 08; 44(8):1642-1647. PubMed ID: 31090329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.